The series C financing will support development of its CLAAS device, an alternative to anticoagulant drugs for atrial fibrillation patients.
Conformal Medical, Inc. has raised $85m in a series C financing to support development of its left atrial appendage closure device for stroke prevention in patients with atrial fibrillation.
The left atrial appendage is a pouch off the left atrium where clots can form in patients with atrial fibrillation and closure of the left atrial appendage reduces the risk...
A Texas court's decision against US FDA regulation of lab-developed tests (LDTs) has introduced new uncertainties for clinical labs. Industry stakeholders are now worried about potential future regulations while also managing existing compliance requirements. Recent conference discussions underscored the complexities of FDA oversight.
A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.
Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.
